Investors Not Impressed With Valeant's New Bid For Allergan

May 28 2014, 11:06am CDT | by

For two weeks, Valeant Pharmaceuticals has been promising to bolster its hostile bid for Allergan to win the widely watched takeover battle. But investors do not seem to be impressed with Valeant’s enhanced $49 billion offer for the maker of Botox.

Valeant increased on Wednesday morning the cash that the company is offering Allergan shareholders by $10 per share to $58.30. Valeant continued to offer the same 0.83 of a Valeant share and added a contingent value right sweetener around Allergan’s experimental vision-loss drug that Valeant claims could result in payments to Allergan shareholders worth as much as $25 a share.

In the tax-driven deals that companies like Valeant have pursued aggressively in recent years, shares of both the acquirer and seller have tended to increase when the deals are announced. Investors, however, sold shares of both Valeant and Allergan on Wednesday. In morning trading, shares of Valeant fell by 2.2% and shares of Allergan dropped by 4.4% to $157.77. Wall Street analysts from Credit Suisse and Wells Fargo said that the new Valeant offer could not be good enough. “We hoped for something more imaginative, like substantially altering the share of cash and stock Valeant will use or a more substantial increase in the value offer,” wrote Aaron “Ronny” Gal, an analyst at Bernstein Research. “The Valeant offer is rather disappointing. It does not really alter the fundamental value of the offer.”

Like a hedge fund manager promoting a short position, Allergan came out swinging against Valeant Pharmaceuticals on Tuesday, questioning whether Valeant’s low tax rate was sustainable and raising other issues surrounding Valeant’s debt-fueled acquisition strategy and accounting. The point was to undermine the appeal to Allergan shareholders of Valeant’s stock, which Valeant is using as currency for its proposed deal. Allergan’s board said on Wednesday that it will review the new Valeant proposal, but Allergan’s board and its CEO, David Pyott, have made it pretty clear they want to keep Allergan an independent company.

During a long presentation on Wednesday to promote his new offer, Valeant CEO Michael Pearson said many of Allergan’s assertion against his acquisition-driven business model were incorrect. “It was a little insulting to be called a Tyco but I guess time will tell,” Pearson said. “This industry the R&D productivity has been very very low, so how all companies grow in this industry is through making really good acquisitions and growing those acquisitions after they make them.”

Pearson, who is working with hedge fund billionaire William Ackman in this takeover effort, said he fully expects Valeant will be successful in its attempt to purchase Botox-maker Allergan. In a sign that he means business, Valeant also announced on Wednesday that it will sell several injectable treatments for facial wrinkles to Nestle for $1.4 billion. At the same time, Pearson was careful to say that he would not be putting together an all-cash deal for Allergan or bid against himself. “We are not going to keep offering against ourselves,” Pearson said. “We are still willing to sit down with management and the board to negotiate a deal, but we are not going to continue increasing our offering until we have that chance to sit down.”

 
 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

Global entrepreneurship summit boost for SMEs
Marrakech, Nov 22 (IANS) Nine agreements were signed between the Moroccan General Confederation of Enterprises (CGEM) and several small and medium enterprises (SMEs) as well as between major Moroccan banks and start-ups at the 5th Global Entrepreneurship Summit (GES 2014) held in Morocco.
 
 
NASA's flying saucer among 'Best of What's New'
Washington, Nov 22 (IANS) NASA's Low-Density Supersonic Decelerator (LDSD), a spacecraft that aims to facilitate the safe landing of future Mars missions, has earned a place in the the Popular Science magazine's "Best Of What's New" list.
 
 
Indian helping to light up Gambia (Diaspora Feature)
Banjul (Gambia), Nov 22 (IANS) Like many Indians who are proving to be philanthropists around Africa, Ram Mohan has set up a social business called Comafrique Intelizon Initiative and has embarked on the replacement of candles in villages in the Gambia with solar lights from India.
 
 
Leopards in human areas not conflict animals: Study
New Delhi, Nov 22 (IANS) Leopards in human areas are not always "stray" or "conflict" animals but residents with strategies to thrive in human dominated areas, says the first GPS-based study of leopards in India.
 
 
 

Latest from the Network

Harry Styles: 'I am a mermaid'
Harry Styles claims he is a mermaid. The One Direction hunk recently got a tattoo of the mythical creature on his forearm and explained he had the image emblazoned on his skin because he is himself, a mermaid. Revealing...
Read more on Celebrity Balla
 
Russell Crowe misses his sons
Russell Crowe says the hardest part about being an actor is not being around his sons. The 'Noah' star finds himself away from home for much of the year due to his busy acting schedule, and admitted he is finding it ''...
Read more on Celebrity Balla
 
28 killed in Kenya attack
Nairobi, Nov 22 (IANS) At least 28 people were killed Saturday in an attack on a bus in Kenya's Mandera county, authorities said. A group of over 100 armed men stopped the Nairobi-bound bus and ordered everyone out at...
Read more on Politics Balla
 
ISL: FC Goa beat FC Pune City to jump to fourth spot
Margao, Nov 22 (IANS) FC Goa beat FC Pune City 2-0 in an Indian Super League (ISL) match at the Jawaharlal Nehru Stadium here Saturday to storm into the top half of the table - into the fourth spot. Winger Romeo...
Read more on Sport Balla
 
Over 900 killed by US-led strikes in Syria
Damascus, Nov 22 (IANS) The US-led anti-terror coalition has killed more than 900 people in its strikes inside Syria during the past 60 days, the Syrian Observatory for Human Rights said Saturday. The casualties...
Read more on Politics Balla
 
Shuttlers Pawar, Saili lose in Scottish Open semis
Glasgow, Nov 22 (IANS) The Indian campaign at the $50,000 Scottish Open Grand Prix came an end as Anand Pawar and Saili Rane lost their respective semi-final matches at the Emirates Arena here Saturday. Spanish second...
Read more on Sport Balla
 
Former Portuguese PM Jose Socrates arrested
Lisbon, Nov 22 (IANS/EFE) Former Portuguese prime minister Jose Socrates has been arrested as part of investigation into the alleged tax fraud, money laundering and corruption. The former Socialist premier was...
Read more on Politics Balla
 
Katy Perry slams Australian 'stalkers'
Katy Perry has slammed the Australian press saying they have ''NO HUMANITY''. The 'This Is How We Do' singer is currently travelling around the country with her 'Prismatic' world tour, and criticised paparazzi in Sydney...
Read more on Celebrity Balla
 
Kendall Jenner feels like Hannah Montana
Kendall Jenner feels like Hannah Montana. The 19-year-old star has forged a career as a fashion model after gaining prominence on hit reality show 'Keeping Up With the Kardashians', and now feels like the Disney Channel...
Read more on Celebrity Balla
 
Philippines renews commitment to resolve Maguindanao massacre
Manila, Nov 22 (IANS) On the fifth anniversary of the Maguindanao massacre Sunday, the Philippine government renewed Saturday its commitment to serve justice to the victims of the worst election-related violence in the...
Read more on Politics Balla